SC
VRTX icon

Slow Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Slow Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.5M Buy
12,307
+963
+8% +$449K 0.71% 47
2025
Q4 		$5.14M Buy
11,344
+44
+0.4% +$19K 0.61% 53
2025
Q3 		$4.43M Sell
11,300
-514
-4% -$215K 0.52% 57
2025
Q2 		$5.26M Sell
11,814
-20
-0.2% -$9.22K 0.64% 44
2025
Q1 		$5.74M Buy
11,834
+198
+2% +$92.3K 0.77% 37
2024
Q4 		$4.69M Sell
11,636
-1,003
-8% -$465K 0.66% 38
2024
Q3 		$5.88M Sell
12,639
-26
-0.2% -$12.5K 0.9% 27
2024
Q2 		$5.94M Sell
12,665
-245
-2% -$106K 0.96% 21
2024
Q1 		$5.4M Sell
12,910
-87
-0.7% -$36.8K 0.86% 25
2023
Q4 		$5.29M Buy
12,997
+51
+0.4% +$18.8K 0.92% 21
2023
Q3 		$4.5M Buy
12,946
+690
+6% +$241K 0.83% 26
2023
Q2 		$4.31M Sell
12,256
-733
-6% -$247K 0.75% 30
2023
Q1 		$4.09M Buy
12,989
+2,809
+28% +$842K 0.77% 33
2022
Q4 		$2.94M Sell
10,180
-264
-3% -$80.5K 0.65% 45
2022
Q3 		$3.02M Buy
10,444
+283
+3% +$81.4K 0.65% 35
2022
Q2 		$2.86M Sell
10,161
-480
-5% -$128K 0.7% 41
2022
Q1 		$2.78M Sell
10,641
-636
-6% -$151K 0.52% 56
2021
Q4 		$2.48M Sell
11,277
-4,111
-27% -$799K 0.42% 86
2021
Q3 		$2.79M Sell
15,388
-44
-0.3% -$8.59K 0.51% 67
2021
Q2 		$3.11M Buy
15,432
+3,033
+24% +$634K 0.59% 56
2021
Q1 		$2.73M Buy
12,399
+1,841
+17% +$404K 0.59% 58
2020
Q4 		$2.5M Buy
10,558
+2,408
+30% +$552K 0.6% 52
2020
Q3 		$2.22M Buy
8,150
+564
+7% +$156K 0.6% 54
2020
Q2 		$2.2M Buy
7,586
+135
+2% +$36.6K 0.65% 47
2020
Q1 		$1.77M Buy
7,451
+695
+10% +$159K 0.67% 50
2019
Q4 		$1.48M Sell
6,756
-246
-4% -$49.8K 0.46% 77
2019
Q3 		$1.19M Buy
7,002
+2,881
+70% +$510K 0.42% 93
2019
Q2 		$756K Buy
+4,121
New +$720K 0.31% 102

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Slow Capital's VRTX Position: Q1 2026 in Review

Slow Capital increased its Vertex Pharmaceuticals (VRTX) stake by 8.5% in Q1 2026, buying an estimated $449K and bringing the position to 12,307 shares worth $5.5M. The position accounts for 0.71% of the portfolio, ranked #47.

Slow Capital first reported a position in VRTX in Q2 2019 and has held it in 28 quarters since. The position peaked at $5.94M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Slow Capital held 12,307 shares of Vertex Pharmaceuticals worth $5.5M as of Q1 2026.
  • Slow Capital bought 963 Vertex Pharmaceuticals shares in Q1 2026, an estimated $449K.
  • Vertex Pharmaceuticals made up 0.71% of Slow Capital's portfolio in Q1 2026, its #47 holding.
  • Slow Capital first reported a position in Vertex Pharmaceuticals in Q2 2019 and has held it in 28 quarters since.
  • Slow Capital's Vertex Pharmaceuticals position peaked at $5.94M in Q2 2024.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Slow Capital's 13F filing for Q1 2026, filed 24 Apr 2026.